Cargando…

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Dawson, S-J, Makretsov, N, Blows, F M, Driver, K E, Provenzano, E, Le Quesne, J, Baglietto, L, Severi, G, Giles, G G, McLean, C A, Callagy, G, Green, A R, Ellis, I, Gelmon, K, Turashvili, G, Leung, S, Aparicio, S, Huntsman, D, Caldas, C, Pharoah, P
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965882/ http://dx.doi.org/10.1038/sj.bjc.6605921

Ejemplares similares

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
por: Dawson, S-J, et al.
Publicado: (2010)

Comparison of methods for handling missing data on immunohistochemical markers in survival analysis of breast cancer
por: Ali, A M G, et al.
Publicado: (2011)

Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival
por: Dawson, S J, et al.
Publicado: (2009)

Decline in Antigenicity of Tumor Markers by Storage Time Using Pathology Sections Cut From Tissue Microarrays
por: Blows, Fiona M., et al.
Publicado: (2016)

Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer
por: Callagy, Grace M, et al.
Publicado: (2008)

Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
por: Ali, H R, et al.
Publicado: (2012)

Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
por: Ali, H Raza, et al.
Publicado: (2011)

The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape
por: Modelska, A, et al.
Publicado: (2015)

Corrigendum to: UNC13B variants associated with partial epilepsy with favourable outcome
Publicado: (2021)

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
por: Ryan, J, et al.
Publicado: (2012)

A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer
por: Koti, M, et al.
Publicado: (2015)

Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases
por: Rajput, Ashish B., et al.
Publicado: (2007)

Dietary patterns and risk of breast cancer
por: Baglietto, L, et al.
Publicado: (2011)

Reply to comment on: ‘Second to fourth digit ratio (2D:4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study'
por: Muller, D C, et al.
Publicado: (2013)

Second to fourth digit ratio (2D : 4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study
por: Muller, D C, et al.
Publicado: (2012)

Corrigendum to “Cardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: Results from the psychological, social and biological determinants of ill health (pSoBid) study” [Neuroimage Clin. 2 (2013) 646–57]
por: Krishnadas, Rajeev, et al.
Publicado: (2015)

PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2
por: Wishart, G C, et al.
Publicado: (2012)

High TNF-α and/or p38MAPK expression predicts a favourable prognosis in patients with T1N0M0 hepatocellular carcinoma: An immunohistochemical study
por: Zhang, Mao, et al.
Publicado: (2019)

Correction to: Ocean warming favours a northern Argyrosomus species over its southern congener, whereas preliminary metabolic evidence suggests that hybridization may promote their adaptation
Publicado: (2023)

Absence of p300 induces cellular phenotypic changes characteristic of epithelial to mesenchyme transition
por: Krubasik, D, et al.
Publicado: (2006)

DICER1 hotspot mutations in non-epithelial gonadal tumours
por: Witkowski, L, et al.
Publicado: (2013)

Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
por: Blows, Fiona M., et al.
Publicado: (2010)

Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL
por: Le Pen, J, et al.
Publicado: (2017)

Bcl-xL controls a switch between cell death modes during mitotic arrest
por: Bah, N, et al.
Publicado: (2014)

MicroRNA-497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl-2
por: Tian, Faqing, et al.
Publicado: (2019)

U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo
Publicado: (2013)

Securidaca–saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells [Corrigendum]
Publicado: (2019)

Astronomical algorithms for automated analysis of tissue protein expression in breast cancer
por: Ali, H R, et al.
Publicado: (2013)

BCL-3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1
por: Tu, Kangsheng, et al.
Publicado: (2022)

Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer
por: Wishart, Gordon C, et al.
Publicado: (2014)

Functional classification of CATH superfamilies: a domain-based approach for protein function annotation
por: Das, Sayoni, et al.
Publicado: (2016)

Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)
por: Phillips, D C, et al.
Publicado: (2016)

Protective effect of sonic hedgehog against oxidized low-density lipoprotein-induced endothelial apoptosis: Involvement of NF-κB and Bcl-2 signaling
por: Huang, Huashan, et al.
Publicado: (2020)

Magnetic Targeting of HU-MSCs in the Treatment of Glucocorticoid-Associated Osteonecrosis of the Femoral Head Through Akt/Bcl2/Bad/Caspase-3 Pathway [Corrigendum]
Publicado: (2021)

[Corrigendum] METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression
por: Zhang, Yongxi, et al.
Publicado: (2023)

Familial relative risks for breast cancer by pathological subtype: a population-based cohort study
por: Mavaddat, Nasim, et al.
Publicado: (2010)

Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort
por: Mukherjee, A., et al.
Publicado: (2018)

Waterborne outbreak of gastroenteritis on the KwaZulu-Natal Coast, South Africa, December 2016/January 2017 – CORRIGENDUM
por: Sekwadi, P. G., et al.
Publicado: (2018)

Associations between parenting behavior and anxiety in a rodent model and a clinical sample: relationship to peripheral BDNF levels
por: Molle, R D, et al.
Publicado: (2013)

Newly established tumourigenic primary human colon cancer cell lines are sensitive to TRAIL induced apoptosis in vitro and in vivo
por: Oikonomou, E, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_h1amdufv8ekf40v44ihthbigl6